Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Effective July 1, 2026: Vietnam Ministry of Health revokes 14 administrative procedures in disease prevention

15/06/2026 Published by Pharma Biz

The Deputy Minister of Health, Assoc. Prof. Dr. Nguyễn Thị Liên Hương, has officially signed a new executive decision disclosing... Read more

Tags: #Vietnam

France recalls Novalac formula batch: Manufacturer isolates root cause of color and odor anomalies

15/06/2026 Published by Pharma Biz

The French government has officially confirmed the voluntary preventive recall of an infant formula batch executed by Novalac following a... Read more

Category: Uncategorized

Tags: #Global Trends

Vietnam Ministry of Health orders urgent recall of French Novalac Allernova AR infant formula batch

15/06/2026 Published by Pharma Biz

The Vietnam Food Safety Administration, operating under the Ministry of Health, has officially dispatched an urgent directive to regional health... Read more

Category: Uncategorized

Tags: #Vietnam

FDA clears expanded approval for Sanofi’s type 1 diabetes drug Tzield in Stage 3 pediatric cohorts

13/06/2026 Published by Pharma Biz

The U.S. Food and Drug Administration (FDA) has formally approved the expanded clinical utilization of Sanofi’s injectable metabolic therapy, Tzield.... Read more

Category: Uncategorized

Tags: #Global Trends

13/06/2026 Published by Pharma Biz

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, has formally applauded the decision issued by... Read more

Category: Uncategorized

Tags: #Global Trends

Gedeon Richter and Hetero Labs secure global alliance to develop and market generic Ozempic®

12/06/2026 Published by Pharma Biz

Gedeon Richter Plc. (Hungary) and Hetero Labs Ltd. (India) have officially announced the execution of a definitive global collaboration agreement... Read more

Category: Uncategorized

Tags: #M&A

Chiesi Group finalizes $1.9 billion acquisition of KalVista Pharmaceuticals to expand rare disease footprint

12/06/2026 Published by Pharma Biz

Chiesi Group, an international research-focused biopharmaceutical corporation and certified B Corp, has officially finalized its corporate acquisition of KalVista Pharmaceuticals... Read more

Category: Uncategorized

Tags: #M&A

Amgen taps Duke Clinical Research Institute to independently review Tavneos data amid FDA withdrawal proposal

12/06/2026 Published by Pharma Biz

U.S. biotechnology giant Amgen has officially retained an independent third-party research institution to conduct an un-biased evaluation of the clinical... Read more

Category: Uncategorized

Tags: #Global Trends

Novartis’ $12 billion RNA asset del-brax logs clinical trial victory in rare muscle-wasting disease

12/06/2026 Published by Pharma Biz

Swiss pharmaceutical giant Novartis has officially announced that its investigational RNA therapeutic, delpacibart braxlosiran (del-brax), successfully satisfied its primary biomarker... Read more

Category: Uncategorized

Posts pagination

Previous page Page 1 … Page 55 Page 56 Page 57 … Page 203 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members